LS Investment Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,255
| Closed | -$108K | – | 1509 |
|
|
2020
Q2 | $108K | Hold |
2,255
| – | – | 0.01% | 956 |
|
|
2020
Q1 | $104K | Hold |
2,255
| – | – | 0.01% | 883 |
|
|
2019
Q4 | $135K | Buy |
2,255
+265
| +13% | +$15.9K | 0.01% | 1002 |
|
|
2019
Q3 | $113K | Hold |
1,990
| – | – | 0.01% | 1030 |
|
|
2019
Q2 | $111K | Buy |
1,990
+33
| +2% | +$1.84K | 0.01% | 1048 |
|
|
2019
Q1 | $99K | Sell |
1,957
-200
| -9% | -$10.1K | 0.01% | 1096 |
|
|
2018
Q4 | $87K | Buy |
2,157
+1,067
| +98% | +$43K | 0.01% | 1108 |
|
|
2018
Q3 | $76K | Sell |
1,090
-197
| -15% | -$13.7K | ﹤0.01% | 1206 |
|
|
2018
Q2 | $97K | Hold |
1,287
| – | – | 0.01% | 1146 |
|
|
2018
Q1 | $68K | Hold |
1,287
| – | – | ﹤0.01% | 1210 |
|
|
2017
Q4 | $69K | Buy |
1,287
+218
| +20% | +$11.7K | ﹤0.01% | 1228 |
|
|
2017
Q3 | $64K | Buy |
1,069
+213
| +25% | +$12.8K | ﹤0.01% | 1274 |
|
|
2017
Q2 | $68K | Hold |
856
| – | – | ﹤0.01% | 1254 |
|
|
2017
Q1 | $71K | Buy |
856
+500
| +140% | +$41.5K | ﹤0.01% | 1233 |
|
|
2016
Q4 | $28K | Hold |
356
| – | – | ﹤0.01% | 1468 |
|
|
2016
Q3 | $25K | Buy |
+356
| New | +$25K | ﹤0.01% | 1455 |
|